APA (7th ed.) Citation

P, M., M, B., A, M., AVD, V., M, C., WM, H., . . . C, L. (2024). Glucagon-Producing Pancreatic Neuroendocrine Tumors (Glucagonomas) are Enriched in Aggressive Neoplasms with ARX and PDX1 Co-expression, DAXX/ATRX Mutations, and ALT (Alternative Lengthening of Telomeres). Endocrine pathology, 35(4), 354. https://doi.org/10.1007/s12022-024-09826-z

Chicago Style (17th ed.) Citation

P, Mattiolo, et al. "Glucagon-Producing Pancreatic Neuroendocrine Tumors (Glucagonomas) Are Enriched in Aggressive Neoplasms with ARX and PDX1 Co-expression, DAXX/ATRX Mutations, and ALT (Alternative Lengthening of Telomeres)." Endocrine Pathology 35, no. 4 (2024): 354. https://doi.org/10.1007/s12022-024-09826-z.

MLA (9th ed.) Citation

P, Mattiolo, et al. "Glucagon-Producing Pancreatic Neuroendocrine Tumors (Glucagonomas) Are Enriched in Aggressive Neoplasms with ARX and PDX1 Co-expression, DAXX/ATRX Mutations, and ALT (Alternative Lengthening of Telomeres)." Endocrine Pathology, vol. 35, no. 4, 2024, p. 354, https://doi.org/10.1007/s12022-024-09826-z.